Skip to main content

Clinical trial PM1183-B-005-14

A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors

Cancers
Organ Multiple
Trial status Trial closed
Investigator
Trial type
Interventional with experimental drug
Phase Trial phase 2
Academic trial Non
Sponsor PharmaMar
EudraCT Identifier 2014-003773-42
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02454972
Inclusion criteria brca 1/2
Last update